3+ YOEPhD in relevant discipline,postdoctoral training or 3+ years translational oncology experience,expertise in tumor profiling and biomarker study design,ability to integrate multimodal datasets and work cross-functionally.
Valius: Provides precision oncology diagnostics and molecular testing for cancer.
Senior/principal scientist experienced in oncology, translating molecular data into treatment options with strong communication to patients and clinicians.
Travere TherapeuticsNASDAQ: TVTX: Developing and selling therapies for rare kidney diseases.
10+ YOE10+ years biopharma experience (6 with PhD), Bachelor’s in life science required; expertise in pharmacology, translational science, disease biology, due diligence, and scientific leadership.
Moffitt Cancer Center: Comprehensive cancer treatment and medical research facility.
5+ YOEPhD or MD/DO required, minimum 5 years at assistant faculty level, proven research track record with publications and extramural funding, ability to develop and maintain independent translational research program, and experience mentoring research personnel.
Century TherapeuticsNASDAQ: IPSC: Develops engineered cell therapies for cancer and autoimmune diseases.
10+ YOEPhD in relevant field, 10+ years industry translational science experience, leadership in early clinical development/biomarkers, assay development and CRO oversight, GCP/GLP familiarity, IND and first-in-human experience preferred.
NS Pharma: Develops and commercializes biopharmaceutical treatments for rare diseases.
8+ YOE8+ years pharmaceutical/biotech R&D experience (PhD/MD) or 12+ years (MS/BS); rare disease experience; translational biomarker and clinical operations expertise; CRO/vendor oversight; contract and budget negotiation; strong leadership and communication.
EisaiTokyo Stock Exchange: 4523: Develops and manufactures pharmaceutical treatments for neurology and oncology.
5+ YOEPhD in a relevant field, 5+ years translational science/biomarker experience, clinical biomarker development knowledge, ability to implement and interpret multimodal biomarkers and collaborate across functions.
AstraZenecaLondon Stock Exchange: AZN: Researches and develops medicines to treat major diseases globally.
PhD with postdoctoral or industry experience; demonstrated experience in bispecifics and ADCs; expertise in biomarker technologies (flow cytometry, IHC, NGS, ctDNA, MRD) and translational strategy for early-phase oncology trials.
5+ YOE5+ years industry experience in translational/biomarker or clinical development; B.S. or M.S. in a scientific discipline; project management experience; stakeholder and vendor coordination; budget and deliverable management.
Associate Director, Translational Program Manager, Solid Tumor Translational Development
Madison or Princeton
$157k-$190k/yrHybridFull Time
Bristol Myers SquibbNew York Stock Exchange: BMY: Develops and distributes innovative medicines for serious diseases.
5+ YOEB.S. or M.S. in a scientific discipline, project management experience/certification desirable, 5+ years pharma/biotech translational/biomarker/clinical development experience, strong stakeholder and program management skills.
SanofiEuronext Paris: SAN: Researches, develops, and manufactures medicines and vaccines globally.
3+ YOEPh.D. in Statistics/Biostatistics, 3+ years translational medicine experience, publication record, strong statistical methodology and computational skills with proficiency in R, plus excellent communication and project skills.
Evvy: A precision women’s health using vaginal microbiome data to improve outcomes.
5+ YOE5–8 years post-PhD/MS in ML on biological data; PhD preferred; strong ML and computational biology skills; Python (PyTorch, scikit-learn); microbiome tools; production experience; cross-functional collaboration.
Stevenage or United Kingdom or Pennsylvania or Cambridge or Waltham or Rockville or San Francisco
$178k-$297k/yrHybridFull Time
GSKLondon Stock Exchange: GSK: Develops and manufactures innovative vaccines and specialty medicines.
Ph.D. in a relevant discipline, Director-level translational science and biomarker experience, expertise in renal/inflammation/fibrosis/neurodegeneration, clinical trial and regulatory experience, external collaboration and program decision-making skills.
BioCryst PharmaceuticalsNASDAQ: BCRX: Develops oral and injectable medicines for rare diseases.
5+ YOEPhD in a quantitative/scientific field, 5+ years pharma/biotech translational modeling experience, strong mechanistic modeling (PBPK, PK/PD, QSP), proficiency in MATLAB/SimBiology, scientific computing, and strong communication skills.
Acadia PharmaceuticalsNASDAQ: ACAD: Develops and sells medicines for neurological and rare diseases.
12+ YOEBachelors in life sciences, 12+ years in translational sciences within pharma/biotech, deep neurology expertise, preclinical and clinical-stage experience, IND/BLA/NDA experience, familiarity with small molecules/ASO/mRNA, data analysis proficiency, willingness to travel.
Solid BiosciencesNASDAQ: SLDB: Develops precision genetic medicines for neuromuscular and cardiac diseases.
10+ YOEPhD/MD required, 10+ years industry experience in discovery/translational development, leadership of programs/teams, experience with IND-enabling development and translational biomarker/assay oversight.